跳至主要内容
临床试验/NCT01958164
NCT01958164已完成3 期

A Multicenter, Open-label, Randomised, Clinical Trial to Compare the Efficacy and Safety of Actilyse 2 mg/ 2 ml Versus Saline Solution in Restoring Function of an Occluded Central Venous Access Device

Boehringer Ingelheim5 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
16
试验地点
5
主要终点
Proportion of Patients With Restored CVAD Function at 120 Min After Administration of the First Dose of Study Medication

研究概览

简要总结

This is a multicentre, open-label, randomised, phase III study designed to evaluate the efficacy and safety of Actilyse 2 mg/2 ml in the restoration of function of CVAD

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Actilyse 2 mg/2 ml

Experimental

First dose of Actilyse 2mg/2ml will be given at time 0. Second dose will be given at 120 if CVAD function has not been restored.

干预措施: Actilyse (Drug)

Saline solution (NaCl 0.9%)

Sham Comparator

Saline solution will be given at time 0. First dose of Actilyse 2mg/2ml will be given to patients if CVAD function has not been restored.

干预措施: Actilyse (Drug)

Saline solution (NaCl 0.9%)

Sham Comparator

Saline solution will be given at time 0. First dose of Actilyse 2mg/2ml will be given to patients if CVAD function has not been restored.

干预措施: Saline solution (Drug)

结局指标

主要结局

Proportion of Patients With Restored CVAD Function at 120 Min After Administration of the First Dose of Study Medication

时间窗: 120 minutes after first drug administration

Proportion (percentage) of patients with restored central venous access device (CVAD) function at 120 min after administration of the first dose of study medication (i.e. Actilyse® or saline solution).

次要结局

  • Restored CVAD Function 30 Minutes After Administration of Study Medication at Time 0(30 minutes after first drug administration)
  • Percentage of Participants Who Achieved Restored CVAD Function After 1 Dose and 2 Doses, in Patients From the Actilyse Treatment Group.(0 minutes and 240 minutes)
  • Restored CVAD Function 30 Minutes After Administration of the Second Dose of Study Medication Actilyse(150 minutes after first drug administration)
  • Restored CVAD Function 120 Minutes After Administration of the Second Dose of Study Medication Actilyse(240 minutes after first drug administration)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

Efficacy and Safety of Actilyse 2 mg/ 2 ml in... | 临床试验